MBRX

Moleculin Biotech News

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Moleculin Biotech Inc MBRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.036 -3.73% 0.9281 0.90 0.9751 0.97 0.9641 20:00:00
more quote information »

Recent News

Date Time Source Heading
7/02/202007:30PRNUSMoleculin Provides Update on Annamycin Clinical Development
7/01/202007:31EDGARCurrent Report Filing (8-k)
7/01/202007:30PRNUSNew Publication Finds Combination of WP1066 and Radiation..
6/29/202008:35GLOBELife Sciences Companies Investor Presentations Now Available..
6/25/202007:31EDGARCurrent Report Filing (8-k)
6/25/202007:30PRNUSMoleculin Announces Preclinical Data Confirms Efficacy of..
6/23/202008:49GLOBEVirtual Conference for Life Sciences Companies Broadcast..
6/23/202007:30PRNUSMoleculin to Present at the Life Sciences Investor Forum
6/17/202016:35EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202016:31EDGARStatement of Changes in Beneficial Ownership (4)
6/17/202016:21EDGARCurrent Report Filing (8-k)
6/16/202007:32EDGARCurrent Report Filing (8-k)
6/16/202007:30PRNUSMoleculin Announces Confirmatory In Vitro Analysis of WP1122
6/04/202007:30PRNUSMoleculin Announces Submission to Expand Clinical Sites in..
6/02/202007:30PRNUSMoleculin Announces Emory University Clinical Trial of..
5/28/202007:30EDGARCurrent Report Filing (8-k)
5/27/202017:55PRNUSMoleculin Announces Common Stock Will Resume Trading on the..
5/27/202017:21EDGARCurrent Report Filing (8-k)
5/27/202016:45GLOBENasdaq Scheduled Resumption in Moleculin Biotech, Inc.
5/27/202016:05PRNUSMoleculin Provides Update on Coronavirus Drug Development
5/18/202016:02EDGARCurrent Report Filing (8-k)
5/18/202008:47GLOBENasdaq Halts Moleculin Biotech Inc.
5/18/202007:30PRNUSMoleculin Announces Nasdaq Trading Halt Pending Receipt of..
5/15/202016:00EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/11/202016:38EDGARQuarterly Report (10-q)
5/11/202007:32EDGARCurrent Report Filing (8-k)
5/11/202007:30PRNUSMoleculin Provides Additional Comments Regarding Trading..
5/08/202007:32EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/08/202007:30PRNUSMoleculin Announces Intention to Adjourn 2020 Annual Meeting..
5/04/202019:37PRNUSMoleculin Announces Trading Halt
4/29/202007:30PRNUSMoleculin to Speak on COVID-19 Panel at Maxim Group's..
4/29/202003:05GLOBEWPD Pharmaceutical’s Annamycin Drug Approved for Accelerated..
4/28/202007:30PRNUSMoleculin Approved to Accelerate European Clinical Trial
4/23/202016:07EDGARCurrent Report Filing (8-k)
4/23/202003:05GLOBEWPD Pharmaceuticals’ Annamycin Drug Candidate Meets Endpoint..
4/22/202007:31EDGARCurrent Report Filing (8-k)
4/22/202007:30PRNUSMoleculin Announces Head of NIAID Antiviral Drug Discovery..
4/21/202007:00GLOBEWPD Pharmaceuticals and CNS Pharmaceuticals Announce..
4/20/202007:30PRNUSMoleculin Announces Agreement with ImQuest Biosciences to..
4/17/202016:05EDGARCurrent Report Filing (8-k)
4/16/202007:30PRNUSMoleculin to Host Investor Conference Call to Discuss..
4/15/202007:31EDGARCurrent Report Filing (8-k)
4/15/202007:30PRNUSMoleculin Announces Leading Virologist Joins Development..
4/14/202007:31EDGARCurrent Report Filing (8-k)
4/14/202007:30PRNUSMoleculin Announces Investor Conference Call to Discuss..
4/10/202006:01EDGARNotice of Effectiveness (effect)
4/09/202003:05GLOBEWPD Pharmaceuticals Reports Active Compound in Licensed Drug..
4/08/202007:31EDGARCurrent Report Filing (8-k)
4/08/202007:30PRNUSMoleculin Announces Active Compound in WP1122 Reduces..
4/07/202016:31EDGARProxy Statement (definitive) (def 14a)
See more news about this stock »


Your Recent History
NASDAQ
MBRX
Moleculin ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.